| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 05/08/2003 | US20030087901 Compounds and methods for modulation of estrogen receptors |
| 05/08/2003 | CA2466424A1 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/08/2003 | CA2464342A1 Therapeutic isoquinoline compounds |
| 05/07/2003 | EP1307184A2 Drugs for incontinence |
| 05/07/2003 | CN1416420A 1,2,3,4-tetrahydroisoquinoline derivatives |
| 05/06/2003 | US6559160 These compounds and compositions bind to the CXCR3 chemokine receptor and are useful for treating diseases and conditions responsive to the modulation of CXCR3 activity, such as multiple sclerosis, rheumatoid arthritis, psoriasis, cancer, |
| 05/02/2003 | EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 05/02/2003 | EP1305291A1 3-substituted isoquinolin-1-yl derivatives |
| 05/02/2003 | EP1305278A1 Ruthenium complexes and their use in asymmetric hydrogenation |
| 05/02/2003 | EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 05/02/2003 | EP0811006B1 Benzopyran-containing compounds and method for their use |
| 05/01/2003 | WO2003035602A1 Lipid modulators |
| 05/01/2003 | WO2002083842A3 Small molecule inhibitors of secretion of proteins encoded by are-mrnas |
| 05/01/2003 | US20030083268 Isoquinoline compounds having antiinfective activity |
| 04/30/2003 | CN1414953A Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and 5-hydroxytryptamine |
| 04/30/2003 | CN1414952A Heterocyclic compounds having sulfonic acid |
| 04/24/2003 | WO2003033617A1 Phosphorescent compounds and devices comprising the same |
| 04/24/2003 | WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 04/24/2003 | US20030078255 6-5, 6-6, or 6-7 Heterobicycles as factor xa inhibitors |
| 04/24/2003 | US20030078249 VLA-4 inhibitor compounds |
| 04/24/2003 | CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/23/2003 | EP1303491A1 Thrombin inhibitors comprising an aminoisoquinoline group |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | CN1413197A 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 04/23/2003 | CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand |
| 04/23/2003 | CN1412182A Tetrahydroisoquinoline derivative with antifungal activity and its preparation method |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552038 Anticoagulant agents |
| 04/22/2003 | US6552019 Inhibitors of p38 |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 04/17/2003 | WO2003030886A2 Allylamides useful in the treatment of alzheimer's disease |
| 04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/17/2003 | US20030072964 For producing high efficiency organic light emitting devices |
| 04/17/2003 | US20030071268 Optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer |
| 04/17/2003 | CA2462875A1 Allylamides useful in the treatment of alzheimer's disease |
| 04/16/2003 | EP1301495A2 Inhibitors of copper-containing amine oxidases |
| 04/16/2003 | EP1301484A2 Capsaicin receptor ligands |
| 04/16/2003 | EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/16/2003 | EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 04/15/2003 | US6548548 Cardiovascular disorders; anticholesterol agents |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548504 Compounds |
| 04/10/2003 | WO2003029221A1 Tetrahydroisochinolines, their production and the use thereof as analgesics |
| 04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2002071827A3 Retinoid x receptor modulators |
| 04/10/2003 | CA2461034A1 Tetrahydroisochinolines, their production and the use thereof as analgesics |
| 04/09/2003 | EP1300464A1 Fungal cell wall synthesis gene |
| 04/09/2003 | EP1299401A1 Chiral ligands for asymmetric catalysis |
| 04/09/2003 | EP1299360A2 Heterocycle carboxamides as antiviral agents |
| 04/09/2003 | CN1409729A Substituted group-4 metal complexes, catalysts and olefin polymerization process |
| 04/09/2003 | CN1105174C Color-safe bleach boosters, compositions and laundry methods employing same |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105100C Compound with anti-inflammatory and immunosuppressive activities |
| 04/08/2003 | US6545055 Amidino-phenyl or -naphthyl aromatic amide derivatives |
| 04/08/2003 | US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa |
| 04/08/2003 | US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane |
| 04/08/2003 | US6545018 Oxamic acids and derivatives as thyroid receptor ligands |
| 04/04/2003 | WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 04/04/2003 | CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 04/03/2003 | WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 04/03/2003 | US20030065176 Anticoagulant; cardiovascular disorders |
| 04/02/2003 | EP1297834A1 Inhibitor for enzyme having two divalent metal ions as active centers |
| 04/02/2003 | EP1296954A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 04/02/2003 | EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/02/2003 | EP1228069B1 Bicyclic and tricyclic heteroaromatic compounds |
| 04/02/2003 | EP0946520B1 Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors |
| 04/02/2003 | EP0882029B1 Heterocyclic derivatives as antidiabetic and antiobesity agents |
| 04/02/2003 | EP0772595B1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof |
| 04/01/2003 | US6541635 Silylprotected L-proline derivative or salt is deprotected in presence of a nonaqueous medium containing an organic solvent at a temperature of 5 degree C. to 40 degree C. |
| 03/27/2003 | WO2003025017A1 Cytokine receptor |
| 03/27/2003 | WO2003024934A2 Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases |
| 03/27/2003 | WO2003024931A1 Tyrosine kinase inhibitors |
| 03/27/2003 | WO2003024453A1 Excitatory amino acid receptor antagonists |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | WO2002101007A3 Antipathogenic benzamide compounds |
| 03/27/2003 | US20030060472 Inhibitor of the enzyme catechol-O-methyl transferase (COMT) |
| 03/27/2003 | US20030056788 Partial liquid breathing of fluorocarbons |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/27/2003 | CA2460151A1 Cytokine receptor |
| 03/26/2003 | EP1294695A2 Substituted diamide derivatives useful as motilin antagonists |
| 03/26/2003 | EP0763026B1 Gastrin and cck antagonists |
| 03/26/2003 | CN1406226A Novel malonic acid derivatives, process for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them |
| 03/26/2003 | CN1103775C Vitronectin receptor antagonists, their preparation and use |
| 03/25/2003 | US6538006 N-heterocyclic moiety-containing hydroxyethylamine protease inhibitor compounds, methods for making the compounds, and intermediates useful in the method. Also, a method for inhibiting retroviral proteases and for treatment of |
| 03/20/2003 | WO2003022810A1 3-amino carbonyl-substituted benzoylcyclohexanediones that can be used as herbicides |
| 03/20/2003 | WO2003022785A2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 03/20/2003 | WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 03/20/2003 | US20030055087 As analgesic |
| 03/20/2003 | US20030054291 Multilayer; radiation transparent substrate, recording media, reflective layer and protective coatings |
| 03/20/2003 | CA2456614A1 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 03/19/2003 | EP1293207A1 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |
| 03/19/2003 | EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 03/19/2003 | EP0931070B1 Hetaroyl cyclohexanedione derivatives with herbicidal effect |